em
Lucentis approved in China
January 18, 2012Sales and Marketing China, Galvus, Lucentis, Novartis, em, emerging markets
Novartis’ eye treatment Lucentis has gained approval in China, and the firm has also launched its diabetes drug Galvus in …
Pfizer extends portfolio with Brazilian generics deal
October 21, 2010Brazil, IMS Health, Pfizer, em, emerging pharma marketings
Pfizer is partnering with leading Brazilian generics firm Laboratorio Teuto Brasileiro to develop and commercialise a number of generic products …
Wellcome Trust signs £45m Indian collaboration
July 30, 2010Research and Development India, Wellcome, em, emerging markets
UK medical research charity the Wellcome Trust and the Indian government are to jointly develop a range of innovative and …
Duncan Learmouth to lead new GSK unit
July 5, 2010Sales and Marketing GlaxoSmithKline, appointment, em, market access, sales and marketing
GlaxoSmithKline has created a new business group dedicated to improving access to medicines in the world’s least developed countries. GSK’s …
GSK acquires Argentine pharma firm
June 11, 2010Sales and Marketing Argentina, GlaxoSmithKline, Latin America, em
GlaxoSmithKline has acquired a leading Argentine pharma firm Laboratorios Phoenix in a move to make further inroads into Latin America. …
Turkey: volatility and growth
May 24, 2010Sales and Marketing Turkey, em
The economic woes of Greece are currently the most worrying problem within the European Union’s single currency region the Eurozone, …
Abbott poised to take top spot in India
May 21, 2010Sales and Marketing Abbott, India, Piramal, em
Abbott has acquired Indian firm Piramal’s Healthcare Solutions business in a deal that is set to make it the number …
Emerging markets key for Merck’s long-term performance
May 13, 2010Research and Development, Sales and Marketing Merck & Co, em
Merck & Co has highlighted emerging markets such as China and Latin America as a major driver for its success …
Abbott strikes emerging markets deal
May 12, 2010Sales and Marketing Abbott, Zydus Cadila, em
Abbott is seeking to extend its reach into emerging markets with a new collaboration with India-based pharma company Zydus Cadila. …
GSK bolsters presence in South Korea
May 11, 2010Sales and Marketing Dong-A, GSK, Korea, em
GlaxoSmithKline has followed through with plans to expand into emerging markets by striking a co-marketing deal with South Korea’s largest …
Emerging markets and generics poised to drive pharma growth
April 20, 2010Sales and Marketing IMS, em, emerging markets
The global pharma market will reach $1.1 trillion in 2014 through growth primarily driven by emerging markets and generics, according …
Hikma expands in Middle East & North Africa
April 15, 2010Manufacturing and Production, Sales and Marketing Hikma, em
UK-headquartered Hikma Pharmaceuticals has signed a flurry of deals that expand its position in the fast-growing Middle East and North …
Indian pharma market ‘impossible to ignore’
April 13, 2010Sales and Marketing India, em
A new report by consultancy firm PricewaterhouseCoopers says that India will become one of the top ten sales markets by …
Russia debates pharma reform
March 30, 2010Sales and Marketing Russia, em, emerging markets
The US is not the only country in the throes of passing significant legislation on major health issues.A bill has …
IMS adds countries to ‘pharmerging’ hit-list
March 18, 2010Sales and Marketing China, IMS, em
IMS Health has added 10 more countries to its list of ‘pharmerging markets’ which represent the future of pharma industry …
